Latest Developments in the Management of Nut Allergies

Overview

Journal Curr Treat Options Allergy

Specialty Allergy & Immunology

Date 2021 Jun 21

PMID 34150446

Citations 2

Authors

H A Brough

R Gourgey

S Radulovic

J C Caubet

G Lack

A Anagnostou

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: In this review, we sought to describe the most recent advances in the dietary and medical management of peanut and tree nut allergy, including selective introduction and immunotherapy.

Recent Findings: Dietary updates include changes to labeling laws, improved information sources, and new apps for buying foods in shops and overseas to better protect individuals with nut allergies. There are still issues in the management of nut allergies in schools, such as parents having to resort to packed lunches instead of school meals and patients experiencing bullying. Air travel also poses concern, but additional resources are now available to travelers, and recent evidence suggest limited airborne exposure to nuts. The medical management of anaphylaxis is use of epinephrine; however, this remains underutilized. Needle length and administration devices have been recently debated considering the risk of bone penetration vs subcutaneous administration, and autoinjectors seem to deliver higher peak concentrations than syringes. Selective nut introduction has gained momentum in the last 5 years, demonstrating improved quality of life but with the need for motivated parents for continued consumption and available resources for challenges. Immunotherapy to nuts is also a rapidly developing field, with the balance of efficacy and safety being important considerations in the differing modes of administration.

Summary: The management of nut allergies is a rapidly developing field, and dietary and medical management have progressed significantly in the last 5 years. Future research directions include improving safety and efficacy of food immunotherapy and examining patients' goals for therapy and treatment outcomes.

Citing Articles

Tree Nut Allergy in Children-What Do We Know? -A Review.

Chudoba A, Zebrowska A, Sybilski A Nutrients. 2024; 16(23).

PMID: 39683372 PMC: 11643764. DOI: 10.3390/nu16233978.

B cells and food allergy.

Udemgba C, Lin A Curr Opin Pediatr. 2021; 33(6):625-632.

PMID: 34354007 PMC: 8571066. DOI: 10.1097/MOP.0000000000001050.

References

Carter C, Pistiner M, Wang J, Sharma H . Food Allergy in Restaurants Work Group Report. J Allergy Clin Immunol Pract. 2020; 8(1):70-74. DOI: 10.1016/j.jaip.2019.09.013. View

Venter C, Sicherer S, Greenhawt M . Management of Peanut Allergy. J Allergy Clin Immunol Pract. 2019; 7(2):345-355.e2. DOI: 10.1016/j.jaip.2018.10.043. View

Stiefel G, Anagnostou K, Boyle R, Brathwaite N, Ewan P, Fox A . BSACI guideline for the diagnosis and management of peanut and tree nut allergy. Clin Exp Allergy. 2017; 47(6):719-739. DOI: 10.1111/cea.12957. View

Elizur A, Appel M, Nachshon L, Levy M, Epstein-Rigbi N, Pontoppidan B . Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study. Lancet Child Adolesc Health. 2019; 3(5):312-321. DOI: 10.1016/S2352-4642(19)30029-X. View

Worm M, Nguyen D, Rackley R, Muraro A, Du Toit G, Lawrence T . Epinephrine delivery via EpiPen Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances. Clin Transl Allergy. 2020; 10:21. PMC: 7285563. DOI: 10.1186/s13601-020-00326-x. View

Brown J . Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device. Ann Allergy Asthma Immunol. 2018; 121(1):53-60. DOI: 10.1016/j.anai.2018.05.001. View

Elizur A, Appel M, Nachshon L, Levy M, Epstein-Rigbi N, Golobov K . NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) study. Allergy. 2017; 73(3):593-601. DOI: 10.1111/all.13353. View

Remington B, Krone T, Kim E, Bird J, Green T, Lack G . Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy. Ann Allergy Asthma Immunol. 2019; 123(5):488-493.e2. DOI: 10.1016/j.anai.2019.08.007. View

Arasi S, Otani I, Klingbeil E, Begin P, Kearney C, Dominguez T . Two year effects of food allergen immunotherapy on quality of life in caregivers of children with food allergies. Allergy Asthma Clin Immunol. 2015; 10(1):57. PMC: 4363059. DOI: 10.1186/1710-1492-10-57. View

10.

Passalacqua G, Nowak-Wegrzyn A, Canonica G . Local Side Effects of Sublingual and Oral Immunotherapy. J Allergy Clin Immunol Pract. 2016; 5(1):13-21. DOI: 10.1016/j.jaip.2016.06.020. View

11.

Virkud Y, Burks A, Steele P, Edwards L, Berglund J, Jones S . Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol. 2016; 139(3):882-888.e5. PMC: 5337444. DOI: 10.1016/j.jaci.2016.07.030. View

12.

Fleischer D, Greenhawt M, Sussman G, Begin P, Nowak-Wegrzyn A, Petroni D . Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019; 321(10):946-955. PMC: 6439674. DOI: 10.1001/jama.2019.1113. View

13.

Bock S, Munoz-Furlong A, Sampson H . Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001; 107(1):191-3. DOI: 10.1067/mai.2001.112031. View

14.

Keet C, Frischmeyer-Guerrerio P, Thyagarajan A, Schroeder J, Hamilton R, Boden S . The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2011; 129(2):448-55, 455.e1-5. PMC: 3437605. DOI: 10.1016/j.jaci.2011.10.023. View

15.

Bird J, Leonard S, Groetch M, Assaad A, Cianferoni A, Clark A . Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report. J Allergy Clin Immunol Pract. 2020; 8(1):75-90.e17. DOI: 10.1016/j.jaip.2019.09.029. View

16.

Waserman S, Avilla E, Ben-Shoshan M, Rosenfield L, Adcock A, Greenhawt M . Epinephrine Autoinjectors: New Data, New Problems. J Allergy Clin Immunol Pract. 2017; 5(5):1180-1191. DOI: 10.1016/j.jaip.2017.06.027. View

17.

Lucendo A, Arias A, Tenias J . Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014; 113(6):624-9. DOI: 10.1016/j.anai.2014.08.004. View

18.

DunnGalvin A, Blumchen K, Timmermans F, Regent L, Schnadt S, Podesta M . APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy. Allergy. 2020; 75(11):2899-2908. PMC: 7689848. DOI: 10.1111/all.14363. View

19.

Muraro A, Roberts G, Worm M, Bilo M, Brockow K, Rivas M . Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014; 69(8):1026-45. DOI: 10.1111/all.12437. View

20.

Santos A, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V . Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. J Allergy Clin Immunol. 2015; 135(1):179-86. PMC: 4282725. DOI: 10.1016/j.jaci.2014.09.001. View